Showing results (661-670 of 695) with videos related to
Sort By:
Pageof 70
The American Journal of Medicine|December 1, 1983
Treatment of extensive stage small cell bronchogenic carcinoma. Effects of variation in intensity of induction chemotherapyM Brower, D C Ihde, A Johnston-Early, et al.JAMA|May 30, 1998
Comparison of molecular changes in lung cancers in HIV-positive and HIV-indeterminate subjectsI I Wistuba, C Behrens, S Milchgrub, et al.The Journal of Laboratory and Clinical Medicine|November 14, 1997
A baboon model for hematologic studies of cardiopulmonary bypassY Hiramatsu, N Gikakis, J H Gorman, et al.Journal of the National Cancer Institute|January 17, 1990
Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive-stage small cell lung cancer: a prospective clinical trialA F Gazdar, S M Steinberg, E K Russell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1984
Diagnosis and significance of liver metastases in small cell carcinoma of the lungJ L Mulshine, R W Makuch, A Johnston-Early, et al.Cancer|December 15, 1982
The clinical behavior of "mixed" small cell/large cell bronchogenic carcinoma compared to "pure" small cell subtypesP A Radice, M J Matthews, D C Ihde, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1986
Combined modality treatment of cutaneous T cell lymphoma: results of a 6-year follow-upC F Winkler, E A Sausville, D C Ihde, et al.The Journal of Thoracic and Cardiovascular Surgery|January 1, 1996
Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypassR C Gorman, N Ziats, A K Rao, et al.Cancer Research|December 26, 2001
Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological featuresR Maruyama, S Toyooka, K O Toyooka, et al.Oncogene|September 12, 2012
Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancerN Sunaga, K Kaira, H Imai, et al.Pageof 70